Posted By :  Admin1

Dr. Gagandeep Kang, currently serving as the Director of Global Health at the Bill and Melinda Gates Foundation, has been honored with the esteemed John Dirks Award in global health, a prestigious recognition in the field. Reflecting on this achievement, Dr. Kang expressed her gratitude, emphasizing the significance of the acknowledgment for the scientific endeavors she and her colleagues have undertaken. Notably, she is the first Indian woman to receive this distinguished award, highlighting her pioneering contributions to improving children's health in India, particularly in combating diarrheal diseases through extensive research on vaccines. Dr. Kang's dedication to this cause extends beyond her tenure at Christian Medical College, Vellore, where she was previously a Professor, to her ongoing efforts post-superannuation. Her continued focus remains on advancing research in childhood diarrhoea and enhancing vaccine development, exemplifying her commitment to public health. Additionally, Dr. Kang's remarkable achievements include being elected as the first Indian woman Fellow of the Royal Society, further solidifying her impact and influence in the scientific community. Established in 1958 through a generous donation from philanthropist James A. Gairdner, the Toronto-based Gairdner Foundation has evolved into Canada's most prestigious accolade for groundbreaking biomedical research conducted worldwide. Annually, five international awards, along with one recognizing advancements in global health, are conferred, each accompanied by a $100,000 prize. Dr. Kang's journey into the field of rotavirus research began at the UK Public Health Laboratory in 1991, igniting a passion that propelled her to conduct groundbreaking research in India and globally over the ensuing three decades. Her pioneering work laid the foundation for the development and widespread adoption of rotavirus vaccines, credited with saving millions of lives. In a recent lecture delivered at the UK Academy of Medical Sciences and published in The Lancet, Dr. Kang underscored how the Indian Rotavirus vaccine story exemplifies the myriad opportunities, essential supportive environments, and challenges inherent in creating products vital to global health.